|
1
|
Furnari FB, Fenton T, Bachoo RM, Mukasa A,
Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, et al:
Malignant astrocytic glioma: Genetics, biology, and paths to
treatment. Genes Dev. 21:2683–2710. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Maher EA, Furnari FB, Bachoo RM, Rowitch
DH, Louis DN, Cavenee WK and DePinho RA: Malignant glioma: Genetics
and biology of a grave matter. Genes Dev. 15:1311–1333. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Takano S, Yamashita T and Ohneda O:
Molecular therapeutic targets for glioma angiogenesis. J Oncol.
2010:3519082010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ferrara N, Gerber HP and LeCouter J: The
biology of VEGF and its receptors. Nat Med. 9:669–676. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Herold-Mende C, Steiner HH, Andl T, Riede
D, Buttler A, Reisser C, Fusenig NE and Mueller MM: Expression and
functional significance of vascular endothelial growth factor
receptors in human tumor cells. Lab Invest. 79:1573–1582. 1999.
|
|
6
|
Li J, Li L, Li Z, Gong G, Chen P, Liu H,
Wang J, Liu Y and Wu X: The role of miR-205 in the VEGF-mediated
promotion of human ovarian cancer cell invasion. Gynecol Oncol.
137:125–133. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wei SC, Tsao PN, Weng MT, Cao Z and Wong
JM: Flt-1 in colorectal cancer cells is required for the tumor
invasive effect of placental growth factor through a p38-MMP9
pathway. J Biomed Sci. 20:392013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fragoso R, Pereira T, Wu Y, Zhu Z,
Cabeçadas J and Dias S: VEGFR-1 (FLT-1) activation modulates acute
lymphoblastic leukemia localization and survival within the bone
marrow, determining the onset of extramedullary disease. Blood.
107:1608–1616. 2006. View Article : Google Scholar
|
|
9
|
Pierzynski JA, Hildebrandt MA, Kamat AM,
Lin J, Ye Y, Dinney CP and Wu X: Genetic variants in the
Wnt/β-catenin signaling pathway as indicators of bladder cancer
risk. J Urol. 194:1771–1776. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mir R, Pradhan SJ, Patil P, Mulherkar R
and Galande S: Wnt/beta-catenin signaling regulated SATB1 promotes
colorectal cancer tumorigenesis and progression. Oncogene.
35:1679–1691. 2016. View Article : Google Scholar
|
|
11
|
Wang G, Zhao Y and Zheng Y:
MiR-122/Wnt/β-catenin regulatory circuitry sustains glioma
progression. Tumour Biol. 35:8565–8572. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yan Z, Che S, Wang J, Jiao Y, Wang C and
Meng Q: miR-155 contributes to the progression of glioma by
enhancing Wnt/beta-catenin pathway. Tumour Biol. 36:5323–5331.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sato F, Tsuchiya S, Meltzer SJ and Shimizu
K: MicroRNAs and epigenetics. FEBS J. 278:1598–1609. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yue S, Wang L, Zhang H, Min Y, Lou Y, Sun
H, Jiang Y, Zhang W, Liang A, Guo Y, et al: miR-139-5p suppresses
cancer cell migration and invasion through targeting ZEB1 and ZEB2
in GBM. Tumour Biol. 36:6741–6749. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li RY, Chen LC, Zhang HY, Du WZ, Feng Y,
Wang HB, Wen JQ, Liu X, Li XF, Sun Y, et al: miR-139 inhibits Mcl-1
expression and potentiates TMZ-induced apoptosis in glioma. CNS
Neurosci Ther. 19:477–483. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang L, Dong Y, Zhu N, Tsoi H, Zhao Z, Wu
CW, Wang K, Zheng S, Ng SS, Chan FK, et al: microRNA-139-5p exerts
tumor suppressor function by targeting NOTCH1 in colorectal cancer.
Mol Cancer. 13:1242014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu W, Hang M, Yuan CY, Wu FL, Chen SB and
Xue K: MicroRNA-139-5p inhibits cell proliferation and invasion by
targeting insulin-like growth factor 1 receptor in human non-small
cell lung cancer. Int J Clin Exp Pathol. 8:3864–3870.
2015.PubMed/NCBI
|
|
19
|
Wang X, Tong X, Gao H, Yan X, Xu X, Sun S,
Wang Q and Wang J: Silencing HIWI suppresses the growth, invasion
and migration of glioma cells. Int J Oncol. 45:2385–2392. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pin AL, Houle F, Fournier P, Guillonneau
M, Paquet ÉR, Simard MJ, Royal I and Huot J: Annexin-1-mediated
endothelial cell migration and angiogenesis are regulated by
vascular endothelial growth factor (VEGF)-induced inhibition of
miR-196a expression. J Biol Chem. 287:30541–30551. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
El Hallani S, Boisselier B, Peglion F,
Rousseau A, Colin C, Idbaih A, Marie Y, Mokhtari K, Thomas JL,
Eichmann A, et al: A new alternative mechanism in glioblastoma
vascularization: Tubular vasculogenic mimicry. Brain. 133:973–982.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Naik S, Dothager RS, Marasa J, Lewis CL
and Piwnica-Worms D: Vascular endothelial growth factor receptor-1
is synthetic lethal to aberrant {beta}-catenin activation in colon
cancer. Clin Cancer Res. 15:7529–7537. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Marumoto T and Saya H: Molecular biology
of glioma. Adv Exp Med Biol. 746:2–11. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lujambio A, Ropero S, Ballestar E, Fraga
MF, Cerrato C, Setién F, Casado S, Suarez-Gauthier A,
Sanchez-Cespedes M, Git A, et al: Genetic unmasking of an
epigenetically silenced microRNA in human cancer cells. Cancer Res.
67:1424–1429. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang Z, Tang H, Wang Z, Zhang B, Liu W,
Lu H, Xiao L, Liu X, Wang R, Li X, et al: miR-185 targets the DNA
methyl-transferases 1 and regulates global DNA methylation in human
glioma. Mol Cancer. 10:1242011. View Article : Google Scholar
|
|
26
|
Huang H, Held-Feindt J, Buhl R, Mehdorn HM
and Mentlein R: Expression of VEGF and its receptors in different
brain tumors. Neurol Res. 27:371–377. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kreisl TN, Kim L, Moore K, Duic P, Royce
C, Stroud I, Garren N, Mackey M, Butman JA, Camphausen K, et al:
Phase II trial of single-agent bevacizumab followed by bevacizumab
plus irinotecan at tumor progression in recurrent glioblastoma. J
Clin Oncol. 27:740–745. 2009. View Article : Google Scholar :
|
|
28
|
Batchelor TT, Mulholland P, Neyns B,
Nabors LB, Campone M, Wick A, Mason W, Mikkelsen T, Phuphanich S,
Ashby LS, et al: Phase III randomized trial comparing the efficacy
of cediranib as monotherapy, and in combination with lomustine,
versus lomustine alone in patients with recurrent glioblastoma. J
Clin Oncol. 31:3212–3218. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Vieira JM, Ruhrberg C and Schwarz Q: VEGF
receptor signaling in vertebrate development. Organogenesis.
6:97–106. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee TH, Seng S, Sekine M, Hinton C, Fu Y,
Avraham HK and Avraham S: Vascular endothelial growth factor
mediates intracrine survival in human breast carcinoma cells
through internally expressed VEGFR1/FLT1. PLoS Med. 4:e1862007.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lichtenberger BM, Tan PK, Niederleithner
H, Ferrara N, Petzelbauer P and Sibilia M: Autocrine VEGF signaling
synergizes with EGFR in tumor cells to promote epithelial cancer
development. Cell. 140:268–279. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Roybal JD, Zang Y, Ahn YH, Yang Y, Gibbons
DL, Baird BN, Alvarez C, Thilaganathan N, Liu DD, Saintigny P, et
al: miR-200 inhibits lung adenocarcinoma cell invasion and
metastasis by targeting Flt1/VEGFR1. Mol Cancer Res. 9:25–35. 2011.
View Article : Google Scholar :
|
|
33
|
Wang F, Yamauchi M, Muramatsu M, Osawa T,
Tsuchida R and Shibuya M: RACK1 regulates VEGF/Flt1-mediated cell
migration via activation of a PI3K/Akt pathway. J Biol Chem.
286:9097–9106. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Takahashi M, Matsui A, Inao M, Mochida S
and Fujiwara K: ERK/MAPK-dependent PI3K/Akt phosphorylation through
VEGFR-1 after VEGF stimulation in activated hepatic stellate cells.
Hepatol Res. 26:232–236. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Arqués O, Chicote I, Puig I, Tenbaum SP,
Argilés G, Dienstmann R, Fernández N, Caratù G, Matito J,
Silberschmidt D, et al: Tankyrase inhibition blocks
Wnt/beta-catenin pathway and reverts resistance to PI3K and AKT
inhibitors in the treatment of colorectal cancer. Clin Cancer Res.
22:644–656. 2016. View Article : Google Scholar
|
|
36
|
Zeitlin BD, Ellis LM and Nor JE:
Inhibition of vascular endothelial growth factor
receptor-1/Wnt/{beta}-catenin crosstalk leads to tumor cell death.
Clin Cancer Res. 15:7453–7455. 2009. View Article : Google Scholar : PubMed/NCBI
|
